|
Report Date : |
20.04.2013 |
IDENTIFICATION DETAILS
|
Name : |
MASE PRODUTOS QUIMICOS E FARMACEUTICOS LTDA |
|
|
|
|
Registered Office : |
Rua Do Grito,268 Anexo 274 - Ipiranga 04217-000 - São Paulo/Sp |
|
|
|
|
Country : |
Brazil |
|
|
|
|
Date of Incorporation : |
13.01.1987 |
|
|
|
|
Legal Form : |
Limited Liability Company |
|
|
|
|
Line of Business : |
Wholesale of Chemical and Pharmaceutical Products. |
|
|
|
|
No. of Employees : |
25 |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Moderate |
|
Payment Behaviour : |
Unknown |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30th, 2012
|
Country Name |
Previous Rating (31.03.2011) |
Current Rating (30.06.2012) |
|
Brazil |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
BRAZIL - ECONOMIC OVERVIEW
Characterized by large and well-developed agricultural,
mining, manufacturing, and service sectors, Brazil's economy outweighs that of all
other South American countries, and Brazil is expanding its presence in world
markets. Since 2003, Brazil has steadily improved its macroeconomic stability,
building up foreign reserves, and reducing its debt profile by shifting its
debt burden toward real denominated and domestically held instruments. In 2008,
Brazil became a net external creditor and two ratings agencies awarded
investment grade status to its debt. After strong growth in 2007 and 2008, the
onset of the global financial crisis hit Brazil in 2008. Brazil experienced two
quarters of recession, as global demand for Brazil's commodity-based exports
dwindled and external credit dried up. However, Brazil was one of the first
emerging markets to begin a recovery. In 2010, consumer and investor confidence
revived and GDP growth reached 7.5%, the highest growth rate in the past 25
years. Rising inflation led the authorities to take measures to cool the
economy; these actions and the deteriorating international economic situation
slowed growth to 2.7% in 2011, and 1.3% in 2012. Unemployment is at historic
lows and Brazil's traditionally high level of income inequality has declined
for each of the last 14 years. Brazil's historically high interest rates have
made it an attractive destination for foreign investors. Large capital inflows
over the past several years have contributed to the appreciation of the
currency, hurting the competitiveness of Brazilian manufacturing and leading
the government to intervene in foreign exchange markets and raise taxes on some
foreign capital inflows. President Dilma ROUSSEFF has retained the previous
administration's commitment to inflation targeting by the central bank, a
floating exchange rate, and fiscal restraint. In an effort to boost growth, in
2012 the administration implemented a somewhat more expansionary monetary
policy that has failed to stimulate much growth.
Source
: CIA
MASE PRODUTOS
QUIMICOS E FARMACEUTICOS LTDA
|
MAIN ADDRESS: |
RUA DO GRITO,268 ANEXO 274 - IPIRANGA |
|
ZIP CODE/CITY: |
04217-000 - SÃO PAULO/SP |
|
|
|
|
PHONE: |
11 2272-0872 |
|
FAX: |
11 3277-2920 |
|
E-MAIL: |
contabilidade@mase.com.br |
|
WEB SITE: |
www.mase.com.br |
|
BRANCHES: |
|
|
|
|
|
ADDRESS: |
RUA JOSE BENTO,125 - CAMBUCI |
|
ZIP CODE/CITY: |
01523-030 SÃO PAULO/SP |
|
MAIN ACTIVITIES: |
|
WHOLESALE OF CHEMICAL AND PHARMACEUTICAL PRODUCTS. |
|
LEGAL FORM: |
LIMITED
LIABILITY COMPANY |
|
|
|
|
INCORPORATION DATE: |
13/01/1987 |
|
REGISTER DATE: |
13/01/1987 |
|
BALANCE SHEET FILING DATE: |
31/12 |
|
TAX CONTRIBUTOR NUMBER(CNPJ): |
56.932.593/0001-89 |
|
STATE REGISTER: |
111.649.900.113 |
|
|
|
|
SHARE CAPITAL: |
R$ 200.000,00 |
|
LAST REGISTER OF CAPITAL: |
26/07/1999 |
|
BOARD OF
DIRECTORS: |
|
|
|
|
|
SÉRGIO MASSARO |
MANAGING PARTNER |
|
THE MANAGING PARTNER IS AUTHORIZED TO SIGN ON BEHALF OF THE COMPANY. |
|
SHAREHOLDERS /
PARTNERS: |
|
|
|
|
|
SÉRGIO MASSARO |
70% |
|
VANESSA MASSARO |
10% |
|
ADRIANA MASSARO RUBIO |
10% |
|
SIMONE MASSARO DE SOUZA |
10% |
|
AFFILIATES /
SUBSIDIARIES: |
|
|
A SCAN THROUGH
OUTSIDE SOURCES SHOWED THE SUBJECT AND/OR DIRECTORS HAS/HAVE THE FOLLOWING
UNCONFIRMED HOLDINGS: |
|
|
CLINICA MASE LTDA |
|
|
THE SUBJECT WAS ESTABLISHED IN 1987 TO BE ENGAGED IN THE SAID LINE OF
BUSINESS AND UP TO DATE IT IS STILL OPERATING WITHIN THE GENERAL SCENE
REPORTED HEREIN. TRADE NAME: MASE. PARTNERS: SÉRGIO MASSARO: BRAZILIAN, HOLDER OF DOCUMENTS CPF 575.313.908-68, RG
42119431 -SP, RESIDENTIAL ADDRESS AT ALAMEDA LACO DE FITA DO 887, A, ITU/SP. VANESSA MASSARO: BRAZILIAN, HOLDER OF DOCUMENTS CPF 312.775.268-77, RG
35770768 -SP, RESIDENTIAL ADDRESS AT RUA MEM DE SA 110, SÃO CAETANO DO
SUL/SP. ADRIANA MASSARO RUBIO: BRAZILIAN, HOLDER OF DOCUMENTS CPF
260.837.498-80, RG 273224049 -SP, RESIDENTIAL ADDRESS AT AV. GUIDO ALIBERTI
4445, CASA 56, SÃO CAETANO DO SUL/SP. SIMONE MASSARO DE SOUZA: BRAZILIAN, HOLDER OF DOCUMENTS CPF
288.531.928-36, RG 327084315 - SP, RESIDENTIAL ADDRESS AT RUAS PALMEIRAS DAS
494, APTO 71, SANTO ANDRE/SP. FURTHER DETAILS ARE SO FAR NOT KNOWN. REMARKS: -------- WHEN INTERVIEWED SOURCES AT THE SUBJECT STATED THAT ARE STILL WAITING
FOR AUTHORIZATION FROM THE PRINCIPALS TO PROVIDE THE DATA NECESSARY TO
COMPLETE THIS REPORT. A REQUEST FOR FURTHER DATA HAS BEEN SENT TO THE COMPANY. PROVIDED THE
DATA REQUESTED ARE RECEIVED FROM THE SUBJECT A COMPLEMENTARY REPORT WILL BE
SENT TO YOUR ATTENTION. THE DATA CONTAINED HEREIN WERE OBTAINED FROM OUTSIDE SOURCES, OUR
DATABASE AND OFFICIAL. NO FURTHER DATA WAS AVAILABLE WITH SEVERAL SOURCES
USUALLY INVESTIGATED. |
|
PUBLIC INFORMATION: |
|
NO DETRIMENTAL FILES WERE FOUND. |
|
DUE TO THE SUBJECT'S LEGAL FORM, IT IS NOT OBLIGED TO PUBLISH THE
BALANCE SHEET INFORMATION. WHEN INTERVIEWING SOURCES AT THE SUBJECT COMPANY
DECLINED TO PROVIDE ANY KIND OF FINANCIAL INFORMATION. OUTSIDE SOURCES CONTACTED SHOWED NO FINANCIAL DATA ABOUT THIS COMPANY.
|
|
EXCHANGE RATE: |
|
|
US$ 1,00 = R$ 1,99 |
- OFFICIAL RATE ON 16/04/2013 |
|
COMMENTS ON THE
FINANCIAL INFORMATION: |
|
IN THE ABSENCE OF FINANCIAL INFORMATION NO COMMENTS CAN BE MADE ABOUT THE
SUBJECT'S CURRENT FINANCIAL STANDING. |
|
REAL ESTATE: |
OWNED PREMISES ARE VALUED AT R$
500.000,00
THE PARTNERS OWN REAL ESTATE
VALUED AT R$ 100.000,00
|
DETAIL OF
RENTED/LEASED REAL ESTATE: |
|
|
|
|
TYPE: |
OTHERS |
|
VALUE: |
R$ ,00 |
|
REMARKS: |
OPERATES FROM RENTED PREMISES. |
|
VEHICLES: |
NOT AVAILABLE
|
MACHINES: |
NOT AVAILABLE
|
INSURANCE COMPANY: |
BANCO DO BRASIL S/A |
|
COVERAGE: |
EQUITY |
|
EXPIRATION: |
NOT AVAILABLE |
|
VALUE: |
R$ 6.000.000,00 |
|
|
BRANCH/PHONE: |
CITY: |
|
BANCO ITAU S/A |
LARGO DO CAMBUCI / 11 3207-7055 |
SÃO PAULO/SP |
|
BANJCO DO BRASIL S/A |
CENTRO / 11 6165-4081 |
SÃO PAULO/SP |
|
BANCO BRADESCO S/A |
ALTO DA MOÓCA / 11 6128-0244 |
SÃO PAULO/SP |
|
REMARKS: IN BRAZIL THE BANKS ARE PROHIBITED BY LAW TO PROVIDE
INFORMATION OR ANY KIND OF COMMENTS ABOUT THEIR CLIENTS. DUE TO THIS LAW
PROHIBITION WE ARE UNABLE TO PROVIDE ANY BANKING DETAILS. ACCORDING TO THE CENTRAL BANK OF BRAZIL OFFICIAL REPORT, THE COMPANY
HAS NO RETURNED CHECKS UP TO DATE. (IN THE TERMS OF "CIRCULAR 1682
BRAZILIAN CENTRAL BANK"). |
|
THE SUBJECT IS ENGAGED IN THE WHOLESALE OF CHEMICAL AND PHARMACEUTICAL
PRODUCTS. |
|
IMPORT AND
EXPORT: |
IMPORTS FROM:
|
ITALY, SWITZERLAND, BELGIUM, SPAIN, ARGENTINA, JAPAN, IRELAND AND HONG
KONG. |
EXPORTS TO:
|
DOES NOT EXPORT. |
|
MAIN CLIENTS: |
|
|
|
|
|
|
|
DOMESTIC
CLIENTS: |
|
PHONE: |
|
ACHE LABORATORIOS FARMACEUTICOS S/A |
|
11 6461-6141 |
|
CATALENT BRASIL LTDA |
|
|
|
DEG IMPORTACAO DE PRODUTOS QUIMICOS LTDA |
|
|
|
DIOSYNTH PRODUTOS FARMOQUIMICOS LTDA |
|
|
|
DM INDUSTRIA FARMACÊUTICA LTDA |
|
|
|
EMS INDUSTRIA FARMACEUTICA LTDA |
|
19 3887-9899 |
|
EMS INDUSTRIA FARMACEUTICA LTDA |
|
19 3887-9899 |
|
JANSEN-CILAG FARMACEUTICA LTDA |
|
12 3932-4042 |
|
LUPER IND. FARMACEUTICA LTDA |
|
11 4035-1066 |
|
MICRO SERVICE IND QUIMICA LTDA |
|
|
|
PURIFARMA DISTRIBUIDORA QUIMICA E FARMACEUTICA LTD |
|
|
|
SINTEFINA IND E COM LTDA |
|
|
|
STAFF: |
|
|
|
THE COMPANY HAS: 25 EMPLOYEE(S) |
|
THE SUBJECT IS A WELL-ESTABLISHED COMPANY, OPERATING SINCE 1987. SO
FAR IT HAS A CLEAR TRADE HISTORY AND NO PAYMENT PROBLEM IS NOTED. NEVERTHELESS, AS MOST OF THE SUPPLIERS, WHICH PROVIDED INFORMATION,
REPORTED PROMPT PAYMENTS IT MAY BE NOTED THAT THE SUBJECT HAS A GOOD PAYMENT
BEHAVIOR. |
|
MAIN SUPPLIERS: |
|
|
|
|
|
|
|
DOMESTIC
SUPPLIERS: |
CITY: |
PHONE: |
|
CAS IMP. E EXP. LTDA |
SÃO PAULO/SP |
11 5677-9696 |
|
DIOSYNTH PRODS FARMO QUIMICOS LTDA |
BARUERI/SP |
11 4196-7979 |
|
EMS S/A |
|
|
|
FARMACIA BUENOS AIRES LTDA |
|
|
|
GLOBE QUIMICA S/A |
|
19 3872-8700 |
|
JANSSEN CILAG FARMACEUTICA LTDA |
|
|
|
LABORATORIOS BALDACCI S/A |
|
|
|
LUPER IND FARMACEUTICA LTDA |
|
|
|
QUIMER COMERCIAL LTDA |
SÃO PAULO/SP |
11 6955-8800 |
|
SELECTCHEMIE IMP. EXP. E REPRESENTAÇÕES LTDA |
SÃO PAULO/SP |
11 5581-6668 |
|
SINTEFINA IND. COM. LTDA |
SÃO PAULO/SP |
11 3813-8581 |
|
FOREIGN
SUPPLIERS: |
|
|
|
ACHE LABORATORIOS FARMACEUTICOS S/A |
|
|
|
DERQUIMICA |
SPAIN |
|
|
F.M.C. INTERNACIONAL |
IRELAND |
|
|
FISCHER CHEMICALS AG |
SWITZERLAND |
|
|
FLAMMA SPA |
ITALY |
|
|
KYOWA MAKKO KOGYO LTD |
JAPAN |
|
|
MEDILON CO |
BELGIUM |
|
|
METCORP LTD |
HONG KONG |
|
|
TRIQUIM |
ARGENTINA |
|
|
PAYMENT HISTORY: |
|
NO PAYMENT RECORD IS REGISTERED. |
|
BASED ON THE OVERALL DATA AVAILABLE THE SUBJECT MAY BE CONSIDERED FOR NORMAL
BUSINESS COMMITMENTS. CREDIT FACILITIES HOWEVER SHOULD BE GRANTED ON FULLY
SECURED TERMS ONLY DUE TO THE ABSENCE OF FINANCIAL DATA. |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.54.03 |
|
|
1 |
Rs.82.43 |
|
Euro |
1 |
Rs.70.49 |
INFORMATION DETAILS
|
Report
Prepared by : |
PRL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this report.
The assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any risk
and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its
officials.